Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muhammad Wasif Saif

Showing results (361-370 of 473) with videos related to

Pageof 48
Sort By:
Anticancer Research|April 12, 2012
Secondary tumors of the pancreas: a case seriesBeiqing Pan, Yoomi Lee, Teresa Rodriguez, et al.
Anticancer Research|November 5, 2014
Safety and efficacy of radiofrequency ablation with aflibercept and FOLFIRI in a patient with metastatic colorectal cancerArchana Agarwal, Kevin Pelham Daly, Harriet Butler-Bowen, et al.
Expert Opinion on Pharmacotherapy|January 17, 2019
Capecitabine for the treatment of pancreatic cancerNauman S Siddiqui, Amandeep Godara, Margaret M Byrne, et al.
JOP : Journal of the Pancreas|July 31, 2014
Pharmacogenetics in pancreatic cancerIoannis S Tourkantonis, Evangelia Peponi, Konstantinos N Syrigos, et al.
JOP : Journal of the Pancreas|March 13, 2012
Management of borderline resectable pancreatic adenocarcinomaYuxia Jia, Tony J C Wang, John Allendorf, et al.
Annals of Gastroenterology|October 7, 2016
Imatinib-induced hyperbilirubinemia with UGT1A1 (*28) promoter polymorphism: first case series in patients with gastrointestinal stromal tumorMuhammad Wasif Saif, Melissa Hennessey Smith, Antonia Maloney, et al.
Cancer Chemotherapy and Pharmacology|March 23, 2006
Radiation recall phenomenon secondary to capecitabine: possible role of thymidine phosphorylaseMuhammad Wasif Saif, Glenda Black, Martin Johnson, et al.
JOP : Journal of the Pancreas|March 12, 2013
Adjuvant therapy of pancreatic cancerChakra P Chaulagain, John Ng, Martin D Goodman, et al.
JOP : Journal of the Pancreas|March 13, 2014
FOLFIRINOX: from the ACCORD study to 2014Georgios M Oikonomopoulos, Konstantinos N Syrigos, Evangelia Skoura, et al.
Expert Opinion on Investigational Drugs|August 24, 2007
IPdR: a novel oral radiosensitizerMuhammad Wasif Saif, Greg Berk, Yung-Chi Cheng, et al.
Pageof 48

Showing results (361-370 of 473) with videos related to

Sort By:
Pageof 48
Anticancer Research|April 12, 2012
Secondary tumors of the pancreas: a case seriesBeiqing Pan, Yoomi Lee, Teresa Rodriguez, et al.
Anticancer Research|November 5, 2014
Safety and efficacy of radiofrequency ablation with aflibercept and FOLFIRI in a patient with metastatic colorectal cancerArchana Agarwal, Kevin Pelham Daly, Harriet Butler-Bowen, et al.
Expert Opinion on Pharmacotherapy|January 17, 2019
Capecitabine for the treatment of pancreatic cancerNauman S Siddiqui, Amandeep Godara, Margaret M Byrne, et al.
JOP : Journal of the Pancreas|July 31, 2014
Pharmacogenetics in pancreatic cancerIoannis S Tourkantonis, Evangelia Peponi, Konstantinos N Syrigos, et al.
JOP : Journal of the Pancreas|March 13, 2012
Management of borderline resectable pancreatic adenocarcinomaYuxia Jia, Tony J C Wang, John Allendorf, et al.
Annals of Gastroenterology|October 7, 2016
Imatinib-induced hyperbilirubinemia with UGT1A1 (*28) promoter polymorphism: first case series in patients with gastrointestinal stromal tumorMuhammad Wasif Saif, Melissa Hennessey Smith, Antonia Maloney, et al.
Cancer Chemotherapy and Pharmacology|March 23, 2006
Radiation recall phenomenon secondary to capecitabine: possible role of thymidine phosphorylaseMuhammad Wasif Saif, Glenda Black, Martin Johnson, et al.
JOP : Journal of the Pancreas|March 12, 2013
Adjuvant therapy of pancreatic cancerChakra P Chaulagain, John Ng, Martin D Goodman, et al.
JOP : Journal of the Pancreas|March 13, 2014
FOLFIRINOX: from the ACCORD study to 2014Georgios M Oikonomopoulos, Konstantinos N Syrigos, Evangelia Skoura, et al.
Expert Opinion on Investigational Drugs|August 24, 2007
IPdR: a novel oral radiosensitizerMuhammad Wasif Saif, Greg Berk, Yung-Chi Cheng, et al.
Pageof 48